Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness

Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy in women worldwide, with an overall 5 year survival rate below 30%. The low survival rate is associated with the persistence of cancer stem cells (CSCs) after chemotherapy. Therefore, CSC-targeting strategies are required fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Heejin, Kim, Jun Woo, Lee, Dong-Seok, Min, Sang-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583017/
https://www.ncbi.nlm.nih.gov/pubmed/33036254
http://dx.doi.org/10.3390/ijms21197379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583017/
https://www.ncbi.nlm.nih.gov/pubmed/33036254
http://dx.doi.org/10.3390/ijms21197379

Ejemplares similares